SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 26.45%1.31B | 26.99%1.24B | 31.26%1.08B | 41.52%3.87B | 34.90%1.04B | 37.23%1.03B | 44.89%978M | 53.08%819M | 60.18%2.73B | 50.00%768M |
Operating revenue | 26.45%1.31B | 26.99%1.24B | 31.26%1.08B | 41.52%3.87B | 34.90%1.04B | 37.23%1.03B | 44.89%978M | 53.08%819M | 60.18%2.73B | 50.00%768M |
Cost of revenue | 21.96%983M | 24.16%956M | 28.06%826M | 36.53%3.03B | 32.79%810M | 34.11%806M | 37.01%770M | 44.62%645M | 59.60%2.22B | 38.95%610M |
Gross profit | 42.48%322M | 37.50%286M | 43.10%249M | 63.21%834M | 43.04%226M | 49.67%226M | 84.07%208M | 95.51%174M | 62.74%511M | 116.44%158M |
Operating expense | 1.05%288M | -3.82%277M | -0.75%264M | 25.25%1.12B | 9.73%282M | 20.76%285M | 35.85%288M | 40.00%266M | 65.13%895M | 35.98%257M |
Selling and administrative expenses | 0.51%199M | -3.06%190M | 0.00%181M | 24.47%763M | 5.62%188M | 22.22%198M | 35.17%196M | 41.41%181M | 61.74%613M | 28.06%178M |
-Selling and marketing expense | 19.00%119M | 15.00%115M | 8.08%107M | 25.71%401M | 17.24%102M | 19.05%100M | 29.87%100M | 39.44%99M | 67.89%319M | 45.00%87M |
-General and administrative expense | -18.37%80M | -21.88%75M | -9.76%74M | 23.13%362M | -5.49%86M | 25.64%98M | 41.18%96M | 43.86%82M | 55.56%294M | 15.19%91M |
Research and development costs | 2.30%89M | -5.43%87M | -2.35%83M | 26.95%358M | 18.99%94M | 17.57%87M | 37.31%92M | 37.10%85M | 73.01%282M | 58.00%79M |
Operating profit | 157.63%34M | 111.25%9M | 83.70%-15M | 25.26%-287M | 43.43%-56M | 30.59%-59M | 19.19%-80M | 8.91%-92M | -68.42%-384M | 14.66%-99M |
Net non-operating interest income expense | -10.00%9M | 11.11%10M | 25.00%10M | 236.36%37M | 66.67%10M | 233.33%10M | 800.00%9M | 8M | 191.67%11M | 6M |
Non-operating interest income | -10.00%9M | 11.11%10M | ---- | ---- | ---- | 233.33%10M | 800.00%9M | ---- | ---- | ---- |
Total other finance cost | ---- | ---- | -25.00%-10M | -236.36%-37M | ---- | ---- | ---- | ---8M | -191.67%-11M | ---- |
Other net income (expense) | -22.22%14M | 80.77%-5M | -2,666.67%-77M | -93.75%6M | 320.00%11M | 190.00%18M | -159.09%-26M | -96.15%3M | 138.40%96M | -104.24%-5M |
Gain on sale of security | -105.56%-1M | 96.15%-1M | -1,300.00%-36M | -96.84%3M | 214.29%8M | 185.71%18M | -159.09%-26M | -96.20%3M | 147.50%95M | -105.93%-7M |
Special income (charges) | --0 | ---4M | ---41M | --0 | --0 | --0 | --0 | --0 | --0 | ---- |
-Less:Restructuring and merger&acquisition | --0 | --4M | --41M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Other non- operating income (expenses) | --15M | ---- | ---- | 200.00%3M | ---- | ---- | ---- | ---- | --1M | --2M |
Income before tax | 283.87%57M | 114.43%14M | -1.23%-82M | 11.91%-244M | 64.29%-35M | 69.61%-31M | -79.63%-97M | -252.17%-81M | 43.47%-277M | -5,000.00%-98M |
Income tax | 1M | 0 | 1M | 200.00%2M | -50.00%1M | 0 | 1M | 0 | 33.33%-2M | 100.00%2M |
Net income | 280.65%56M | 114.29%14M | -2.47%-83M | 10.55%-246M | 64.00%-36M | 68.37%-31M | -81.48%-98M | -252.17%-81M | 43.53%-275M | -10,100.00%-100M |
Net income continuous Operations | 280.65%56M | 114.29%14M | -2.47%-83M | 10.55%-246M | 64.00%-36M | 68.37%-31M | -81.48%-98M | -252.17%-81M | 43.53%-275M | -10,100.00%-100M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 280.65%56M | 114.29%14M | -2.47%-83M | 10.55%-246M | 64.00%-36M | 68.37%-31M | -81.48%-98M | -252.17%-81M | 43.53%-275M | -10,100.00%-100M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 280.65%56M | 114.29%14M | -2.47%-83M | 10.55%-246M | 64.00%-36M | 68.37%-31M | -81.48%-98M | -252.17%-81M | 43.53%-275M | -10,100.00%-100M |
Basic earnings per share | 266.67%0.1 | 115.79%0.03 | 0.00%-0.15 | 14.81%-0.46 | 63.16%-0.07 | 68.42%-0.06 | -72.73%-0.19 | -200.00%-0.15 | 67.86%-0.54 | -4,857.14%-0.19 |
Diluted earnings per share | 177.78%0.07 | 110.53%0.02 | 6.25%-0.15 | 34.72%-0.47 | 63.16%-0.07 | 52.63%-0.09 | -72.73%-0.19 | 20.00%-0.16 | 57.14%-0.72 | 17.39%-0.19 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |